ICER Releases Final Report on ‘Abuse-Deterrent’ Opioids

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2vfGBSs on August 8, 2017 at 04:57PM

The Institute for Clinical and Economic Review on Tuesday released a Final Evidence Report on abuse-deterrent opioids, saying there is insufficient evidence to suggest the drugs are “effective in reducing overall abuse of opioids at a population level.”

ICER logo for Berger reportAccording to a press release, ICER reviewed nine releases of abuse-deterrent formulations (ADFs) for the report.

“ICER’s report found very little evidence on the impact of ADFs on abuse in clinical practice, and there is some evidence suggesting that ADFs can lead those trying to abuse the drug to switch to other, potentially more dangerous drugs, including heroin and fentanyl,” ICER says in a press release.

“Those opioid formulations today being identified as “abuse-deterrent” – which our report suggests should more accurately be called “tamper-resistant” – will certainly be part of broader strategies to combat the opioid epidemic,” ICER Chief Science Officer Dan Ollendorf said.

Click here to read the full press release on ICER’s website.

Advertisements